Cargando…
Usefulness of Simultaneous Magnetic Resonance Neurography and Apparent T2 Mapping for the Diagnosis of Cervical Radiculopathy
STUDY DESIGN: Retrospective observational study. PURPOSE: We investigated the correlation between T2 relaxation times and clinical symptoms in patients with cervical radiculopathy caused by cervical disk herniation. OVERVIEW OF LITERATURE: There are currently no imaging modalities that can assess th...
Autores principales: | Enomoto, Keigo, Eguchi, Yawara, Sato, Takashi, Norimoto, Masaki, Inoue, Masahiro, Watanabe, Atsuya, Sakai, Takayuki, Yoneyama, Masami, Aoki, Yasuchika, Orita, Sumihisa, Narita, Miyako, Inage, Kazuhide, Shiga, Yasuhiro, Umimura, Tomotaka, Sato, Masashi, Suzuki, Masahiro, Takaoka, Hiromitsu, Mizuki, Norichika, Kim, Geundong, Hozumi, Takashi, Hirosawa, Naoya, Furuya, Takeo, Maki, Satoshi, Nakamura, Junichi, Hagiwara, Shigeo, Koda, Masao, Akazawa, Tsutomu, Takahashi, Hiroshi, Takahashi, Kazuhisa, Ohtori, Seiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Spine Surgery
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873997/ https://www.ncbi.nlm.nih.gov/pubmed/34000796 http://dx.doi.org/10.31616/asj.2020.0668 |
Ejemplares similares
-
Frequency of Adverse Drug Reactions and Analgesic Effects of Mirogabalin during Treatment of Peripheral Neuropathic Pain: A Retrospective Clinical Investigation
por: Inage, Kazuhide, et al.
Publicado: (2020) -
Time-Course Changes in Bone Metabolism Markers and Density in Patients with Osteoporosis Treated with Romosozumab: A Multicenter Retrospective Study
por: Inage, Kazuhide, et al.
Publicado: (2021) -
Background factors for chronic low back pain resistant to cognitive behavioral therapy
por: Shimizu, Keisuke, et al.
Publicado: (2021) -
Radiological Assessment of Damage to the Iliopsoas Muscle by the Oblique Lateral Interbody Fusion Approach
por: Inoue, Masahiro, et al.
Publicado: (2019) -
Improvements in Intractable Lumbar and Lower-Extremity Symptoms after Systemic Administration of Tocilizumab, an Anti-interleukin-6 Receptor Antibody
por: Sainoh, Takeshi, et al.
Publicado: (2022)